Home > Cashflow Statement > BALAXI PHARMACEUTICALS

BALAXI PHARMACEUTICALS
Cashflow Statement

BALAXI PHARMACEUTICALS is part of below Screeners ↓
Top Undervalued Small Cap Stocks
COMMUNITY POLL
for BALAXI PHARMACEUTICALS
Please provide your vote to see the results

BALAXI PHARMACEUTICALS Last 5 Year Cashflow Statement History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Profit Before Tax₹29 Cr₹2.02 Cr₹57 Cr₹55 Cr₹44 Cr
Adjustment ₹7.43 Cr₹-1.14 Cr₹8.03 Cr₹1.18 Cr₹-0.59 Cr
Changes In working Capital ₹-68 Cr₹11 Cr₹-47 Cr₹-16 Cr₹-41 Cr
Cash Flow after changes in Working Capital ₹-32 Cr₹12 Cr₹18 Cr₹40 Cr₹2.60 Cr
Cash Flow from Operating Activities ₹-35 Cr₹4.87 Cr₹6.08 Cr₹34 Cr₹0.00 Cr
Cash Flow from Investing Activities ₹-22 Cr₹-1.05 Cr₹-11 Cr₹-28 Cr₹-5.97 Cr
Cash Flow from Financing Activities ₹34 Cr₹30 Cr₹26 Cr₹-0.16 Cr₹3.65 Cr
Net Cash Inflow / Outflow ₹-23 Cr₹34 Cr₹21 Cr₹5.53 Cr₹-2.32 Cr
Opening Cash & Cash Equivalents ₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr₹3.98 Cr
Cash & Cash Equivalent on Amalgamation / Take over / Merger -----
Cash & Cash Equivalent of Subsidiaries under liquidations -----
Translation adjustment on reserves / op cash balalces frgn subsidiaries -----
Effect of Foreign Exchange Fluctuations -----
Closing Cash & Cash Equivalent ₹39 Cr₹62 Cr₹28 Cr₹7.19 Cr₹1.66 Cr

Compare Cashflow Statement of peers of BALAXI PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS ₹138.6 Cr -9.2% -24% -67.3% Stock Analytics
ADANI ENTERPRISES ₹280,700.0 Cr -3.9% -4.6% -11.6% Stock Analytics
REDINGTON ₹21,045.4 Cr -5.7% -3.8% 35.1% Stock Analytics
MMTC ₹9,519.0 Cr -5% 17.5% -16.9% Stock Analytics
HONASA CONSUMER ₹9,339.7 Cr -4.3% 11.9% 18.2% Stock Analytics
LLOYDS ENTERPRISES ₹9,319.6 Cr -7.6% 9.3% 16.9% Stock Analytics


BALAXI PHARMACEUTICALS Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
BALAXI PHARMACEUTICALS

-9.2%

-24%

-67.3%

SENSEX

-1.8%

-0.6%

7.3%


You may also like the below Video Courses